|
Dan Suesskind is the Chief Financial Officer of Teva Pharmaceutical Industries Ltd. the largest generic drug company in the world a position he has held since 1978. He served as a director of Teva until 2001 and is currently a member of the Jerusalem Foundation Investment Advisory Committee the Board of Trustees of Hebrew University Migdal Insurance Company and Ness Technologies Inc.
| 